Research at Radial

Backed by research.
Driven by care.

Radial clinicians don't just follow the research, they conduct it. From neuromodulation to digital psychiatry, our team actively publishes and participates in clinical trials, ensuring every patient receives care that is grounded in the best available evidence.

Publications

April 2026
Accelerated TMS
Accelerated TMS with the H1-coil for depression: A multisite, randomized non-inferiority trial
Colleen A. Hanlon, Yiftach Roth, Richard A. Bermudes, Eliza Brink, Molly Davis, Dawn DeBrocco, Shelli Ellis, Lindsey Jones, Aftab Khan ∙ Carlene MacMillan, Aswin Kumar Mudunuru, Owen Muir, Gabriel S. Pell, Timothy Prestley, M.S. Reddy, Adi Rachelson, Elyssa Sisko, Samson Seplow, Natanya Slomowitz, Ahava Stein, Daniel B. Thistlethwaite, Russ Voltin, Aron Tendler
Can depression be treated just as effectively in days instead of weeks? This multisite randomized trial shows accelerated TMS delivers comparable patient outcomes to standard treatment—while significantly reducing time to relief.
Depression
Accelerated TMS
April 2026
TMS
Patient-reported outcomes following accelerated vs. standard TMS with the H1 coil for major depression: A multisite randomized trial
Tendler A, Roth Y, Bates M, Brink E, Davis M, DeBrocco D, Ellis S, Jones L, Khan A, Luce S, McMillan C, Mudunuru AK, Muir O, Pell GS, Prestley T, Reddy MS, Rodriguez N, Seplow S, Slomowitz N, Stein A, Thistlethwaite DM, Voltin R, Williams N, Hanlon CA.
What does recovery actually feel like for patients — and does it matter how fast treatment happens? This multisite randomized trial found that accelerated TMS delivers patient-reported improvements in depression, anxiety, and quality of life comparable to standard treatment, with faster perceived relief.
Depression
Anxiety
TMS
OCD
Deep TMS
Personality Disorders
Narcissism
Mentalizing-Based Therapy
Personality Disorders
Mentalizing-Based Therapy
Depression
Deep TMS
Depression
Deep TMS
Personality Disorders
Mentalizing-Based Therapy
Personality Disorders
Mentalizing-Based Therapy
Depression
Deep TMS
Movement Disorders
AI / Digital Psychiatry
OCD
Deep TMS
Depression
Deep TMS
Depression
Deep TMS
Depression
Deep TMS
Depression
Ketamine Monitoring
PTSD
Bipolar
TMS
Movement Disorders
AI / Digital Psychiatry
Depression
Accelerated TMS
Movement Disorders
AI / Digital Psychiatry
Depression
Accelerated TMS
OCD
Deep TMS
Depression
Accelerated TMS
Depression
Anxiety
TMS
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Psychedelic Therapy
Depression
Deep TMS
Personality Disorders
Mentalizing-Based Therapy
Depression
Accelerated TMS
Depression
Anxiety
Accelerated TMS
Depression
Accelerated TMS
OCD
Deep TMS
Depression
Deep TMS
Depression
Deep TMS
Depression
Accelerated TMS
Depression
Deep TMS
Depression
Accelerated TMS
Depression
Ketamine Therapy
Filter Publications
Conditions
Treatments
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Active Clinical Trials

AI / Digital Psychiatry

Cross-Dataset Evaluation of an Automated Video-Based Model for Detecting Tardive Dyskinesia Using the Clinician's Tardive Inventory: Validation Study

Can AI reliably spot a movement disorder that clinicians routinely miss? This validation study found that an AI-powered video analysis model accurately detected tardive dyskinesia — a common side effect of long-term antipsychotic use — even when video recordings weren't collected under standardized conditions. The model showed strong agreement with expert clinician ratings and high diagnostic accuracy, suggesting it could support earlier, more consistent screening in real-world clinical settings.
View
Trosch R, Sterns A, Grimm B, Larsen L, Talbot B, Ma F, Ranjan R, MacMillan C, Hughes J, Friedman J, Muir O
Can AI reliably spot a movement disorder that clinicians routinely miss? This validation study found that an AI-powered video analysis model accurately detected tardive dyskinesia — a common side effect of long-term antipsychotic use — even when video recordings weren't collected under standardized conditions. The model showed strong agreement with expert clinician ratings and high diagnostic accuracy, suggesting it could support earlier, more consistent screening in real-world clinical settings.

Leadership

Dr. Owen Scott Muir

Co-founder & Chief Medical Officer

MD, DFAACAP

Dual board-certified child, adolescent and adult psychiatrist, and author of the award-winning Frontier Psychiatrists newsletter and podcast

Read more

Dr. Carlene MacMillan

Co-founder & Chief Product Officer

MD, FCTMSS, DFAACAP

Dual board-certified child, adolescent, and adult psychiatrist focused on expanding access to breakthrough treatments through better technology and insurance coverage advocacy.

Read more

John Capecelatro

CEO & Co-Founder

Elliot Cohen

Executive Chairman & Co-Founder

Stephanie Fillion

VP of Engineering

Jonathan Murray

Chief Commercial Officer

Leah Connor

VP of Operations

Take the first step and talk to a care navigator.

Your care navigator will explain the process, discuss insurance and costs, and connect you with a clinician to explore today’s most advanced mental health treatments.